GILD | Gilead Sciences Inc
Category: Biotechnology company
Quick infos Headquarters: Foster City, California, United States Trade prices Volume: 1.3M Market Cap: 78.22B Prev closed: 59.05 Open: 58.44 High: 61.45 Low: 58.18 52 week low: 57.04 52 week high: 85.97 Dividends: Next ER: February 7, 2023
About the Company Gilead Sciences is an American biopharmaceutical company that discovers, develops and commercializes drugs.
Earnings History Date EPS / Forecast Revenue / Forecast February 2, 2023 - / 1.51- / 6.65BOctober 27, 2022 1.9 / 1.527B / 6.13BBeat! August 2, 2022 1.58 / 1.526.26B / 5.86BBeat! April 28, 2022 2.12 / 1.86.59B / 6.29BBeat! February 1, 2022 0.69 / 1.597.24B / 6.61BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 17, 2022 66.02 65.97 66.89
65.82
6.44M -0.47% Aug 16, 2022 66.33 66.16 66.42
65.65
7.06M 0.18% Aug 15, 2022 66.21 63.85 66.30
63.66
12.38M 5.16% Aug 12, 2022 62.96 62.71 62.99
62.15
4.00M 0.82% Aug 11, 2022 62.45 62.78 63.41
62.37
5.20M -1.09% Aug 10, 2022 63.14 62.49 63.19
62.11
8.25M 1.84% Aug 9, 2022 62.00 61.58 62.05
61.38
5.15M 0.65% Aug 8, 2022 61.60 61.00 61.71
60.81
5.86M 0.83% Aug 5, 2022 61.09 61.79 61.84
60.62
6.04M -1.32% Aug 4, 2022 61.91 62.14 62.99
61.83
5.51M -0.58% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US3755581036 CUSIP: 375558103 Founded:June 1987 Employees:9,000 News
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know finance.yahoo.com Feb 3, 2023 5:50 pm UPDATE 1-Gilead buys out rights to cancer therapy from Jounce for $67 mln finance.yahoo.com Feb 3, 2023 5:31 pm Gilead stock jumps 5% after Q4 beat, dividend increase finance.yahoo.com Feb 3, 2023 5:14 pm
Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics finance.yahoo.com Feb 3, 2023 4:30 pm Arcus, Gilead Disappoint As Lung-Cancer Regimen Lags Rival Roche finance.yahoo.com Feb 3, 2023 4:07 pm
Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend finance.yahoo.com Feb 3, 2023 4:05 pm Gilead Issues Unexpectedly Bullish Outlook After Cancer Drug Sales Rocket finance.yahoo.com Feb 3, 2023 4:00 pm
Gilead's twice-a-year HIV drug Sunlenca approved by FDA finance.yahoo.com Feb 3, 2023 2:25 pm
Gilead (GILD) Gets FDA Nod for Twice-Yearly HIV Treatment finance.yahoo.com Feb 3, 2023 12:27 pm
Gilead (GILD) To Get Full Rights for Jounce's Immunotherapy finance.yahoo.com Feb 3, 2023 10:59 am UPDATE 2-U.S. FDA approves Gilead's long-acting HIV drug Sunlenca finance.yahoo.com Feb 3, 2023 10:44 am
Gilead Sciences: Connecting Breast Cancer Education to Community: Equal Hope finance.yahoo.com Feb 3, 2023 10:00 am
This New Drug Could Be Gilead Sciences' Growth Catalyst finance.yahoo.com Feb 3, 2023 9:20 am
Covid Isnt Going Away. New Drugs Are Coming. finance.yahoo.com Feb 3, 2023 9:00 am
Decades-Long Effort to Enact Universal HIV Screening for Pregnant Women in Israel finance.yahoo.com Feb 3, 2023 9:00 am
Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma finance.yahoo.com Feb 3, 2023 9:00 am
Could Gilead Sciences Stock Help You Become a Millionaire? finance.yahoo.com Feb 3, 2023 8:55 am
2 Unstoppable Stocks That Could Beat the Market Again In 2023 finance.yahoo.com Feb 3, 2023 8:45 am
Is Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE Of 16% Concerning? finance.yahoo.com Feb 3, 2023 7:00 am
Gilead Sciences, Inc. (NASDAQ:GILD) Delivered A Weaker ROE Than Its Industry finance.yahoo.com Feb 3, 2023 7:00 am GILD Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Dec 14, 2022 0.73 Dec 29, 2022 Sep 14, 2022 0.73 Sep 29, 2022 Jun 14, 2022 0.73 Jun 29, 2022 Mar 14, 2022 0.73 Mar 30, 2022 Dec 14, 2021 0.71 Dec 30, 2021 view more
Key Persons CEO : John F. Milligan, PhD Talk about Gilead Sciences Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: gilead.com Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
